Innovations in Pharmaceutical Glaucoma Management: ROCK Inhibitors in NTG

I. Paul Singh, MD; and Zarmeena Vendal, MD

Show Description +

Zarmeena Vendal, MD, and I. Paul Singh, MD, discuss the role of pharmaceuticals in the management of glaucoma, especially in the context of normal tension glaucoma. Also in this episode, Dr. Vendal shares data from her recent study that evaluated how IOP is affected when either netarsudil 0.02% (Rhopressa, Alcon) or brimonidine 0.1% (Alphagan) was added to latanoprost 0.005% monotherapy in normal tension glaucoma patients.

Posted: 5/01/2026

Keywords:

Normal Tension Glaucoma

•

Pharmaceutical Management

•

Interventional Glaucoma

Up Next

Innovations in Dry Eye Management: Considerations for Real-World Practice

I. Paul Singh, MD; and Eric Donnenfeld, MD

Redefining Success in the Era of Interventional Glaucoma

I. Paul Singh, MD; and Christine M. Funke, MD

Innovations in Glaucoma Surgery: A Protocol for Integrating Interventional Principles

I. Paul Singh, MD; and Christine M. Funke, MD

$Innovations in Refractive Surgery: The Implantable Collamer Lens$

Innovations in Refractive Surgery: The Implantable Collamer Lens

I. Paul Singh, MD; and William F. Wiley, MD

Innovations in Presbyopia Management: The Role of Drop Therapy

I. Paul Singh, MD; and Marjan Farid, MD

Innovations in Cataract Surgery: Going Dropless

I. Paul Singh, MD; and Cathleen M. McCabe, MD

$Innovations in Refractive Cataract Surgery: Light-Adjustable Lenses$

Innovations in Refractive Cataract Surgery: Light-Adjustable Lenses

I. Paul Singh, MD; and John Doane, MD

Innovations in MIGS: Evolutions in Canaloplasty

I. Paul Singh, MD; and Damien F. Goldberg, MD

Innovations in Ophthalmic Practice: Work-Life Balance

I. Paul Singh, MD; and Darrell E. White, MD

Innovations in Astigmatism Management: Long-term Stability of Arcuate Incisions

I. Paul Singh, MD; and Denise M. Visco, MD, MBA

Innovations in Glaucoma: Procedural Pharmaceuticals

I. Paul Singh, MD; and Steven R. Sarkisian Jr, MD

Treatment Burden in AMD: Implications for Patients and Providers

I. Paul Singh, MD; and Carl D. Regillo, MD

Innovations in AMD Therapy: Second-Generation Anti-VEGFs

I. Paul Singh, MD; and Carl D. Regillo, MD

Innovations in IOLs: Advancements in Monofocal Lens Technology

I. Paul Singh, MD; and Julie Schallhorn, MD

Innovations in MIGS: The Impact of Reimbursement Changes

I. Paul Singh, MD; and Sahar Bedrood, MD, PhD

Innovations in Medical Glaucoma: Preservative-Free Latanoprost

I. Paul Singh, MD; and Jason Bacharach, MD

Innovations in Dry Eye Treatment: Crosslinked Hyaluronic Acid Gel Occlusive

I. Paul Singh, MD; and Brandon D. Ayres, MD

Innovations in Glaucoma: The Corneal Safety of MIGS Implant Devices

I. Paul Singh, MD; and Arsham Sheybani, MD

Innovations in MIGS: The FLIGHT Procedure

I. Paul Singh, MD; and Robert J. Noecker, MD, MBA

Innovations in Presbyopia Management: Laser Scleral Microporation

I. Paul Singh, MD; and Mitchell A. Jackson, MD

Innovations in Retina: Gene Therapy

I. Paul Singh, MD; and David Eichenbaum, MD

Innovations in Glaucoma: Real-World Evidence

I. Paul Singh, MD; and Joe Panarelli, MD

Innovations in Cornea: Managing Low Astigmatism

I. Paul Singh, MD; and Gary Wörtz, MD

Innovations in Point of Service: Office-Based Surgery

I. Paul Singh, MD; and Daniel S. Durrie, MD

Innovations in Premium IOLs: Small-Aperture Lenses

I. Paul Singh, MD; and Karl G. Stonecipher, MD

Innovations in Dry Eye: The Expanding Toolkit

I. Paul Singh, MD; and John A. Hovanesian, MD, FACS

Innovations in Ocular Surface Disease: What is the Impact of Lifestyle?

I. Paul Singh, MD; and Christopher E. Starr, MD

Innovations in Cornea: What are FGFs?

I. Paul Singh, MD; and Nandini Venkateswaran, MD

Innovations in MIGS for the Anterior Segment Surgeon

I. Paul Singh, MD; and Blake K. Williamson, MD, MPH, MS

Innovations in Geographic Atrophy

I. Paul Singh, MD; and Charles C. Wykoff, MD, PhD, FACS

Innovations in …Mydriasis?

I. Paul Singh, MD; and Marguerite McDonald, MD, FACS

Innovations in AI: Applications in Ophthalmology

I. Paul Singh, MD; and Ranya Habash, MD

Innovations in Cataract Surgery: Let's Talk Technique!

I. Paul Singh, MD; and J. Morgan Micheletti, MD

Innovations in Astigmatism Management: Torics, LRIs, and Combinations

I. Paul Singh, MD; and Cathleen M. McCabe, MD

Innovations in Blepharitis: Prevalence and New Treatment Options

I. Paul Singh, MD; and Laura M. Periman, MD

Innovations in MIGS: A Look at the Pipeline

I. Paul Singh, MD; and Leonard K. Seibold, MD

Getting Patients to Open Up

I. Paul Singh, MD; and Darrell E. White, MD

Innovations in Vitreous Floaters: Laser Vitreolysis

I. Paul Singh, MD; and Darrell E. White, MD

Innovations in Innovation: How to Get Involved in Research

I. Paul Singh, MD; and Sila Bal, MD, MPH

Innovations in Ergonomics: Heads-Up Surgery

I. Paul Singh, MD; and Arjan Hura, MD

Getting Involved in Research

I. Paul Singh, MD; and Dagny Zhu, MD

Innovations in Social Media: Harnessing the Power of the Medium

I. Paul Singh, MD; and Dagny Zhu, MD

Innovations in IOLs: EDOF, IC-8, and LAL

I. Paul Singh, MD; and William F. Wiley, MD

Innovations in Retina: PDS for AMD and ART for Complex MH

I. Paul Singh, MD; and Steve Charles, MD, FACS, FICS

Innovations in Glaucoma: State of the Science in Canaloplasty

I. Paul Singh, MD; and Mark J. Gallardo, MD

Innovations in Presbyopia: An Expanding Category

I. Paul Singh, MD; and Ralph Chu, MD

$Innovations in Refractive Surgery: Sophisticated Surgical Planning Software$

Innovations in Refractive Surgery: Sophisticated Surgical Planning Software

I. Paul Singh, MD; and Mark Lobanoff, MD

Innovations in Glaucoma: Microinvasive Bleb Procedures vs Trabeculectomy

I. Paul Singh, MD; and Sahar Bedrood, MD, PhD

Innovations in Cornea: Genetic Testing in KC and Nasal Spray for DED

I. Paul Singh, MD; and Brandon D. Ayres, MD

Innovations in MIGS: Long-Term Data and the Growing Interest in Viscodilation

I. Paul Singh, MD; and Nathan M. Radcliffe, MD

Innovations in IOLs: What it Really Means to Deliver Intermediate Vision

I. Paul Singh, MD; and James A. Katz, MD

Canaloplasty: Benefits of Treating the Anatomy

I. Paul Singh, MD; and Mark J. Gallardo, MD

Back to All Videos

Innovations in Pharmaceutical Glaucoma Management: ROCK Inhibitors in NTG

I. Paul Singh, MD; and Zarmeena Vendal, MD

Posted: 5/01/2026

Keywords:

Normal Tension Glaucoma

•

Pharmaceutical Management

•

Interventional Glaucoma

Please log in to leave a comment.

Editorial Feature:

Innovation Journal Club

Innovations in Pharmaceutical Glaucoma Management: ROCK Inhibitors in NTG

Up Next

Innovations in Pharmaceutical Glaucoma Management: ROCK Inhibitors in NTG

Editorial Feature:

Innovation Journal Club

Innovations in Pharmaceutical Glaucoma Management: ROCK Inhibitors in NTG

Up Next

Innovations in Pharmaceutical Glaucoma Management: ROCK Inhibitors in NTG

Related Videos